The estimated Net Worth of Robert J Hariri is at least 733 千$ dollars as of 19 August 2024. Robert Hariri owns over 1,000 units of CryoPort Inc stock worth over 179,645$ and over the last 12 years he sold CYRX stock worth over 162,862$. In addition, he makes 390,408$ as Independent Director at CryoPort Inc.
Robert has made over 19 trades of the CryoPort Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he sold 1,000 units of CYRX stock worth 9,470$ on 19 August 2024.
The largest trade he's ever made was buying 25,250 units of CryoPort Inc stock on 31 August 2015 worth over 43,178$. On average, Robert trades about 1,896 units every 89 days since 2012. As of 19 August 2024 he still owns at least 23,061 units of CryoPort Inc stock.
You can see the complete history of Robert Hariri stock trades at the bottom of the page.
Dr. Robert J. Hariri M.D., Ph.D. serves as Independent Director of the Company. serves as Independent Director of the Company. Dr. Hariri became a member of our board of directors in September 2015 and serves as Chairman of the Scientific and Technology Committee and member of the Audit Committee and Nomination and Governance Committee of our board of directors. Dr. Hariri is a visionary surgeon, scientist, aviator and entrepreneur and serves the Founder, Chairman and CEO of Celularity, one of the world’s largest human cellular therapeutics companies. Previously, he served as the CEO of the Cellular Therapeutics Division of Celgene Corporation. Prior to joining Celgene Cellular Therapeutics as president in 2002, Dr. Hariri was founder, chairman and chief scientific officer at Anthrogenesis Corporation/LIFEBANK, Inc., a privately held biomedical technology and service corporation involved in the area of human stem cell therapeutics, which was acquired by Celgene in 2002. Dr. Hariri is also co-founder and president of Human Longevity, Inc., a genomics and cell-therapy company. He serves on numerous Boards of Directors including Bionik Laboratories Corp (OTCQX: BNKL), Myos Corporation (Nasdaq: MYOS), Provista Diagnostics and is a member of the Board of Visitors of the Columbia University School of Engineering &Applied Sciences and the Science &Technology Council of the College of Physicians and Surgeons; as well as a member of the Scientific Advisory Board for the Archon X PRIZE for Genomics, which is awarded by the X Prize Foundation. Dr. Hariri is also a Trustee of the Liberty Science Center and has been appointed Commissioner of Cancer Research by New Jersey Governor, Chris Christie. Dr. Hariri was recipient of the Thomas Alva Edison Award in 2007 and 2011, and has received numerous other honors for his many contributions to biomedicine and aviation.
As the Independent Director of CryoPort Inc, the total compensation of Robert Hariri at CryoPort Inc is 390,408$. There are 6 executives at CryoPort Inc getting paid more, with Jerrell Shelton having the highest compensation of 3,839,460$.
Robert Hariri is 61, he's been the Independent Director of CryoPort Inc since 2015. There are 4 older and 5 younger executives at CryoPort Inc. The oldest executive at CryoPort Inc is Richard Berman, 77, who is the Lead Independent Director.
Robert's mailing address filed with the SEC is C/O CRYOPORT INC.112, WESTWOOD PLACE, SUITE 350, BRENTWOOD, TN, 37027.
Over the last 12 years, insiders at CryoPort Inc have traded over 202,268,038$ worth of CryoPort Inc stock and bought 80,292 units worth 196,910$ . The most active insiders traders include Holdings Ii L.P.Blackstone ...、Richard J Berman、Jerrell Shelton. On average, CryoPort Inc executives and independent directors trade stock every 39 days with the average trade being worth of 414,958$. The most recent stock trade was executed by Robert J Hariri on 19 August 2024, trading 1,000 units of CYRX stock currently worth 9,470$.
cryoport delivers an innovative and complete outsourced frozen shipping solution for biological materials. this breakthrough combination replaces outdated dry ice shipping, virtually eliminates the risk of cell degradation and revolutionizes deep frozen logistics. we combine the technology of liquid nitrogen dry vapor shippers with the most advanced logistics management platform in the industry. when added with our logistics expertise, we provide a complete outsourced solution that advances deep-frozen shipping for the life science community. whether your business is bio-pharmaceuticals, clinical trials, research or reproductive medicine, you want to focus on your core mission. cryoport will help you transport life.
CryoPort Inc executives and other stock owners filed with the SEC include: